News about Biotechnology, Pharmaceutical and Healthcare

11:25 EDT 22nd September 2017 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 41,000+

Friday 22nd September 2017

arium® mini: Ultrapure Water System with Unique Bagtank Technology

Sartorius presents a new system for laboratories needing low volumes of ultrapure water With arium® mini, the laboratory and pharmaceutical equipment supplier Sartorius offers an especially compact ultrapure water system. This newly developed system delivers a flow rate of one liter per minute and is specially designed for ultrapure water requirements of less than 10 liters per day.

Company Spotlight: Flexion Therapeutics

Shares of Flexion Therapeutics Inc. (FLXN) are up 40% so far this year, well ahead of the iShares NASDAQ Biotech Index ETF (IBB), which has returned only 25% during the same period.

Patient and Public Involvement (PPI) with the Haematology and Stem Cells theme

Patient and Public Involvement (PPI) takes many forms, but the objective is always the same. Only by carrying out our research with patients can we ever hope to do work that is meaningful and of high quality. Medicine and research are a genuine partnership between patients, doctors and scientists. If you wanted to get involved, ... Read more

Synthetic Biology and Immunotherapy to Bring More Effective Cell Therapies for Cancer

The post Synthetic Biology and Immunotherapy to Bring More Effective Cell Therapies for Cancer appeared first on SynBioBeta.

Meet Laura Adam, an Expert in Design Automation in Synthetic Biology

The post Meet Laura Adam, an Expert in Design Automation in Synthetic Biology appeared first on SynBioBeta.

Bespoke Filtration Equipment Enables Pharma Manufacturer to Fulfil Critical Contract

Amazon Filters has supplied a major pharmaceutical manufacturer with bespoke filtration equipment enabling them to fulfil a contract to deliver critical drugs to a leading children’s hospital. Faced with a shortfall of the required critical drugs, as they couldn’t get the right filtration equipment to filter them and carry on production, the pharmaceutical manufacturer turned to Amazon...

Krystal Microplate Enables Development of Drug Testing Assay for Plasmodium vivax

Porvair Sciences reports that the National Center for Biological Sciences (NCBS) in Bangalore, India is using its Krystal 384 black microplate to produce a standard drug testing assay for Plasmodium vivax infection. The NCBS is a leading national institute whose faculty members undertake research in the frontier areas of biology. Scientists at the NCBS use experimental and computational approaches...

Scientists Discover Potential New Improved Way to Kill Cancer Cells

Scientists at the University of Glasgow have discovered a process to trigger the death of cancer cells that could be more effective than current methods. The new method of killing cancer cells – called Caspase Independent Cell Death (CICD), and published today in Nature Cell Biology, led to the complete eradication of tumours in experimental models. A short video explaining the process with ...

Alnylam soars on likely first RNAi treatment approval

Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for its efforts. Revealing data from its treatment, patisran, for Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy, the results are strong enough to make the long wait for first treatment worthwhile. read more

19 deaths from liver drug causes Intercept shares to tumble

Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a result of its treatment – that concerned escalated as the FDA announced 19 people in total had died. In the initial letter sent out to health care providers (HCPs), Intercept warned of patient deaths that had resulted from patients being dosed more frequently than recommend...

NICE recommends Bayer's Eylea for myopic chorodial neovascularisation

Bayer has revealed that UK drug regulator NICE has given its final recommendation on blockbuster eye drug Eylea (aflibercept solution for injection) in the treatment of visual impairment due to myopic chorodial neovascularisation (mCNV), advising that it be made available to patients on the NHS in England and Wales. read more

New therapy offers triple threat to HIV virus

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to effectively protect all animals treated with the antibody. The antibody is unusual by design as it is has been engineered to latch onto the HIV virus at three different points, and early research suggests this could be key to overcoming resistance from the virus. The therapy is deri...

Versartis Loses VELOCITY - What Other Pharma Stocks Made News This Week?

Shares of Versartis Inc. (VSAR) plunged over 83% in extended trading on Thursday, following disappointing results from its phase III study of Somavaratan, dubbed VELOCITY.

Thursday 21st September 2017

IPXL Mulls Merger, QURE Attracts Attention, No Let Up In ICPT Ocaliva Concerns

The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of September 21, 2017.

Manchester company Zilico help raise awareness of Gynae Cancer

A Manchester cervical cancer diagnostic company, is helping to raise awareness of the five gynaecological cancers - womb, ovarian, cervical, vaginal and vulval - in support of Gynaecological Cancer Awareness Month.Throughout September, Zilico, who are based on the Manchester Science Park, is supporting the UK campaign run by The Eve Appeal, to help more people become aware of the early signs and s...

High Force Research sets sights on North America

Leading North East-based chemical research and development company, High Force Research, is looking across the Atlantic as it sets its sights on growth.Founded nearly three decades ago, High Force Research is one of the UK’s longest trading and most successful independent chemical research and development companies. The company specialises in supporting the development, synthesis and scale u...

CHMP positive opinion to include RE-CIRCUIT® data for atrial fibrillation patients undergoing catheter ablation in Pradaxa® Summary of Product Characteristics

Monday, September 18th 2017 at 7:08am UTC The CHMP of the EMA has issued a positive opinion for an update of the Summary of Product Characteristics (SmPC) for Pradaxa® (dabigatran etexilate) The CHMP recommends to include data showing that catheter ablation can be conducted in patients on 150 mg twice daily Pradaxa®, without interrupting Pradaxa® … Cet article CHMP positive opinion to inc...

Dr. Robert Emery Joins HealthTech Solutions as Chief Scientific Officer

Tuesday, September 19th 2017 at 3:00pm UTC IOWA CITY, Iowa–(BUSINESS WIRE)– Emerging health IT start-up HealthTech Solutions has named Robert Emery MD as Chief Scientific Officer. Dr. Emery will oversee the company’s research, funded by a recent SBIR Phase 1 grant, on using intelligent communication technology to reduce organ waste and improve efficiency in the … Cet article Dr...

Ignyta to Present at Cantor Fitzgerald 2017 Global Healthcare Conference

Wednesday, September 20th 2017 at 11:00am UTC SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make a presentation at the Cantor Fitzgerald 2017 Global Healthcare Conference on Wednesday, September 27, 2017, at 1:05 p.m. Eastern time (10:...

PAREXEL International Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management

Monday, September 18th 2017 at 1:00pm UTC BOSTON–(BUSINESS WIRE)– PAREXEL International Corporation (NASDAQ: PRXL) (« PAREXEL » or the « Company »), a leading global biopharmaceutical services company, announced today that its shareholders, at a special meeting held on September 15, 2017 in Boston, Massachusetts, approved the previously announced...

AgeX Therapeutics CEO Michael D. West to Participate in Fireside Chat with J. Craig Venter at the Cell & Gene Therapy CEO Forum

Thursday, September 21st 2017 at 11:00am UTC ALAMEDA, Calif.–(BUSINESS WIRE)– AgeX Therapeutics, Inc. (AgeX), a subsidiary of BioTime, Inc. (NYSE American: BTX), announces that Chief Executive Officer Michael D. West, Ph.D., who also serves as Co-CEO of BioTime, is participating in a fireside chat at Cell & Gene Therapy CEO on Monday, September 25, 2017 … Cet article AgeX The...

IDbyDNA and ARUP Laboratories Introduce Explify Respiratory: Breakthrough Technology to Diagnose Pneumonia Caused by Previously Undetected Pathogens

Tuesday, September 19th 2017 at 11:30am UTC Metagenomics test identified pathogens missed by conventional lab tests in 44 percent of immunocompromised children treated for respiratory infection SAN FRANCISCO & SALT LAKE CITY–(BUSINESS WIRE)– ARUP Laboratories and IDbyDNA, Inc., a data analytics-driven metagenomics company, announce the launch of Explify™ Respiratory, a novel next...

Q&A: PerceptiMed’s Maione talks engaging patients through Rx tech

Drug Store News spoke to PerceptiMed chief business officer Frank Maione about how PerceptiMed is working to help pharmacies deliver on the goal of improved patient engagment.  read more

Target grows reach of Restock next-day delivery

Marianne WilsonTarget is rolling out its next-day delivery service of household essentials, Target Restock, to eight new markets. read more

iMedicare, Mirixa partner on new integration

David SalazarThe integration of iMedicare’s plan comparison platform into Mirixa’s MirixaPro platform will enable pharmacies to take advantage of medication-related opportunities within their everyday workflow by prioritizing available clinical interventions for each specific patient. read more

Quick Search